パラセタモールの濃度と極度に早産の新生児におけるダクトス・アテリアス・ダイアミターの時間経過:集団の薬理動力学分析
Faheemah Padavia1,2, Jean-Marc Treluyer3,4,5,6, Gilles Cambonie7,8
1Université Paris Cité, Inserm, Pharmacologie et évaluation des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. faheemah.padavia@aphp.fr.
Clinical pharmacokinetics
|September 1, 2025
まとめ
静脈内投与のパラセタモールは 非常に早産の赤ん坊の静脈管を 効果的に閉じます NSAIDに対する潜在的に安全な代替品を提供する.
科学分野:
- 新生児薬理学
- 小児心臓科
- 薬剤測定法
背景:
- 非常に早産の乳児では頻繁に発生する合併症である.
- インドメタシンやイブプロフェンのような 現在の治療法では 死亡率や発症率が低下していません
- パラセタモールは,より安全な予防治療法です.
研究 の 目的:
- 静脈内パラセタモールが動脈管の直径に及ぼす効果について,薬学動力学モデル (PKPD) を開発する.
- 極端に早産した新生児に対するパラセタモールの投与療法の有効性を評価する.
主な方法:
- PKPDモデルは,エフェクトコンパートメントを備えたIMAXモデルを使用して構築されました.
- 非常に早産した新生児 (妊娠23~26週) は5日間,予防用IVパラセタモールを投与された.
- デュアダクトス動脈の直径は,500人の仮想患者でPKPDモデリングによる濃度シミュレーションにより,毎日モニタリングされた.
主要な成果:
- 異なる最大抑制値 (Imax) を有する2つのサブ集団が特定されました (99%と42%).
- 吸入した酸素と換気は,移転速度の定数 (ke0) に影響した.
- パラセタモルの高用量 (25 mg/ kg 増量,10 mg/ kg 維持用) は最大抑制の95%を早く達成し,患者の90%以上が1日目までに値に達した.
結論:
- PKPDモデルでは,非常に早産の新生児におけるダクトス動脈の直径に対するパラセタモールの効果を効果的に記述しています.
- IVパラセタモールは,特に25 mg/kgの負荷用量と6時間ごとに10 mg/kgの負荷用量で,管の閉塞を加速します.
- 投与量を増やすと,追加の効果は限られている.
関連する概念動画
01:15Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
194
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
194
01:14Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382